US Drug Watchdog Expands Its National Initiative Involving the Osteoporosis Drug Fosamax and Women W
The US Drug Watchdog is dramatically expanding its national initiative involving the osteoporosis drug called Fosamax, and women who may have suffered out of the blue fractures to their femur, or thigh bone. According to the FDA, "typically these fractures occurred after using Fosamax for five years, or more." The US Drug Watchdog says, "In the instance of Fosamax, we are talking about women, whose leg simply broke. They did not fall, they did not run into something, their femur bone simply broke. We need to identify every woman in the United States, who had been using Fosamax
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 309
- Bankruptcy 44
- Business 133
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4